Adaptive Biotechnologies Corp - COM (ADPT)

Historical Portfolio Holders from Q3 2016 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
143M
Holdings value Q3 2024
$732M
Value change Q3 2024
-$27.7M
Grand Portfolio weight change Q3 2024
0%
Number of holders
184
Number of buys Q3 2024
94
Number of sells Q3 2024
-62
Average buys Q3 2024 %
+0.002%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 143M $732M -$27.7M $5.12 185
2024 Q2 149M $538M +$26.5M $3.62 174
2024 Q1 142M $456M -$11.7M $3.21 185
2023 Q4 144M $704M +$13.7M $4.90 194
2023 Q3 140M $761M +$10M $5.45 185
2023 Q2 137M $920M +$21.9M $6.71 207
2023 Q1 134M $1.18B +$14M $8.83 222
2022 Q4 133M $1.01B +$14.8M $7.64 215
2022 Q3 131M $931M -$31.4M $7.12 203
2022 Q2 134M $1.08B +$49M $8.09 197
2022 Q1 126M $1.74B -$42.4M $13.88 207
2021 Q4 123M $3.46B +$140M $28.06 207
2021 Q3 118M $4B -$434K $33.99 211
2021 Q2 117M $4.79B +$143M $40.86 224
2021 Q1 114M $4.58B -$123M $40.26 237
2020 Q4 114M $6.74B +$149M $59.13 243
2020 Q3 111M $5.41B +$503M $48.63 207
2020 Q2 101M $4.88B +$213M $48.38 193
2020 Q1 96.8M $2.69B +$284M $27.78 144
2019 Q4 86.2M $2.58B +$149M $29.92 130
2019 Q3 81M $2.49B +$38.9M $30.90 116
2019 Q2 78.2M $3.74B +$3.73B $48.30 110
2019 Q1 104K $4.25M $0 $40.86 1
2016 Q4 0 $0 -$10.1K 0
2016 Q3 235 $10.1K +$10.1K $43.05 1